Despite standard hormonal therapy that targets the androgen receptor (AR) attenuates
prostate cancer (PCa) effectively in the initial stage, the tumor ultimately converts to …

Prostate cancer (PC) represents the most diagnosed and the second most lethal cancer in
men worldwide. Its development and progression occur in concert with alterations in the …

Flavonoids are a ubiquitous group of plant metabolites, which exhibit therapeutic potential
like anticarcinogenic and antidiabetic activities through various cellular signaling pathways …

Prostate cancer (PCa) is a non-cutaneous malignancy in males with wide variation in
incidence rates across the globe. It is the second most reported cause of cancer death. Its …

Exosomes are considered to be a rich source of biomarkers, hence in this article we
examine the best procedure for their isolation. We examine several isolation procedures …

A total of 20% to 50% of prostate cancer (PCa) patients leave the surgery room with positive
tumour margins. The intraoperative combination of fluorescence guided surgery (FGS) and …

At present, there are no cancer treatments that are both non‐invasive and highly accurate.
New tests that can diagnose cancer at an early stage would help to facilitate such improved …

The way cells communicate is not fully understood. However, it is well-known that
extracellular vesicles (EVs) are involved. Researchers initially thought that EVs were used …

Prostate cancer (PC) is one of the most widespread malignancies among males worldwide.
The androgen receptor (AR) plays a major role in prostate cancer development and …

Circular RNAs (circRNAs) are a major type of cargos encapsulated in extracellular vesicles
(EVs) and regulate the progression of prostatic cancer (PC). This study was conducted to …